Private Market View

Aminex Therapeutics

Kenmore, WA · Founded 2009 · Privately Held (backing)

Last price · $/share
Implied valuation
$105.1M
Total raised
$47.6M
Last round
Early Stage VC
Oct 2022
What is Aminex Therapeutics worth?
$105.1Mlast known valuation

Aminex Therapeutics last raised $15.1M in its Early Stage VC (Oct 2022).

Free account
See the evidence behind this price
  • ·Post-money valuations for all 6 rounds
  • ·The complete investor list — 1 names
  • ·Watchlist + deal alerts for Aminex Therapeutics
Create free account
No card required

Funding history

6 rounds
DateRoundRaisedPost-money
Oct 2022Early Stage VC$15.1M
Aug 2021Early Stage VC$6.3M
Jul 2020Debt$2.9M
May 2018Early Stage VC$8.3M
Oct 2014Seed Round$410K
Jun 2014Seed Round$1.6M

How Aminex Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Aminex Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

What is Aminex Therapeutics worth?
Aminex Therapeutics's last known valuation is $105.1M.
How much has Aminex Therapeutics raised?
Aminex Therapeutics has raised $47.6M in total funding across 6 recorded rounds.
When did Aminex Therapeutics last raise?
Aminex Therapeutics last raised in Oct 2022 (Early Stage VC), raising $15.1M.